NASDAQ
OM
Last Price
US $4.25
Valuation
Financial
Performance
Cash flow to debt coverage
Outset Medical, Inc. cash flow to debt ratio of -45.76% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Outset Medical, Inc.'s free cash flow has increased -59.80% from $-117.22M last year to $-47.12M, signaling increasing performance
Debt-to-equity ratio
Outset Medical, Inc.'s debt to equity ratio is 1.08, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Outset Medical, Inc.'s debt has decreased relative to shareholder equity from 7.53 last year to 1.08 today, signaling strengthened financials
Net debt to EBITDA
Outset Medical, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Outset Medical, Inc.'s interest coverage ratio is -4.81, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Outset Medical, Inc.'s profit margin has increased (-43.98%) in the last year from -112.57% to -63.06%, signaling increasing performance
Current ratio
Outset Medical, Inc.'s short-term assets of $250.88M exceed its short-term liabilities of $37.63M
Return on assets
Outset Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Outset Medical, Inc.'s return on equity of -62.25%, is lower than 15.00%, indicating bad performance
Earnings quality
Outset Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Outset Medical, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Outset Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Outset Medical, Inc. has negative free cash flow, indicating cash burn
Earnings growth
Outset Medical, Inc.'s yearly earnings has increased -36.20% since last year from $-127.98M to $-81.65M, signaling increasing performance
Revenue growth
Outset Medical, Inc.'s yearly revenue has increased 5.09% since last year from $113.69M to $119.48M, signaling increasing performance
Return on invested capital
ROIC -32.84% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Outset Medical, Inc.'s 3-year revenue CAGR of 1.17% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Outset Medical, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Outset Medical, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Outset Medical, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Outset Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Outset Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Outset Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Outset Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Outset Medical, Inc. has a price-to-book ratio of 0.95x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Outset Medical, Inc. has a price-to-sales ratio of 0.78x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-62.25%
Return on equity
ROIC: -32.84%
Valuation History
-
Price to Earnings
EV/EBITDA: -2.6X
Cash flow
Profit margin
12.99%
Cash flow
18.07%
Fair Value
Market $4.25
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.